Oramed’s Oravax Medical and Genomma Lab Internacional in Mexico partner to develop and commercialize Oramed's oral COVID-19 vaccine .

The oral COVID-19 vaccine developed by Israel's Oramed Pharmaceuticals will be taken by 24 unvaccinated volunteers this month.

To mark World Diabetes Day, NoCamels looks at some of Israel’s most innovative diabetes-related technologies, from insulin injection replacements to blood glucose meters and tissue engineering.

Oramed Pharmaceuticals is in the process of developing insulin pills for the treatment of diabetes. The company is enetring a phase 2 clinical trial in the U.S and hoping to deliver the pills to the market by 2016.